IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,611 | +15.2% | 32,047 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $195,807 | +95415.6% | 32,047 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $205 | -99.9% | 32,054 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $308,000 | -13.2% | 32,119 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $355,000 | -33.8% | 32,119 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $536,000 | -12.8% | 32,201 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $615,000 | -98.3% | 32,201 | -97.8% | 0.00% | -98.3% |
| Q3 2021 | $35,937,000 | -6.7% | 1,457,308 | -1.5% | 0.12% | -12.2% |
| Q2 2021 | $38,502,000 | +3242.2% | 1,479,719 | +3967.5% | 0.13% | +2520.0% |
| Q1 2021 | $1,152,000 | – | 36,379 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |